Enumera Molecular
Precision Medicine · Bioinformatics
$31Mtotal raised · 2 rounds on record
$12.3Mlatest round · Venture round · Jul 2026 · 3 mo ago
1backers · Arboretum Ventures
13team · US Form 5500 (plan participants) · Dec 2025 · -46% in a year
Overview
At Enumera Molecular we are transforming the field of complex diagnostic testing to a simpler, cost-effective tool for physicians to benefit patient care.
Funding and backers
Total raised
$31M
2 rounds on record
Latest round
$12.3M
Venture round · Jul 2026 · 3 mo ago
Team
13
US Form 5500 (plan participants) · Dec 2025 · -46% in a year
Backers
1
Arboretum Ventures
The money's age
Fresh money
3 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 31
Board appointment Sundaresh Brahmasandra, Director · SEC Form D
Jul 16
Raised a round Venture round $12.3M · SEC Form D
2025
Team shrank to 13 was 24 · US Form 5500 (plan participants)
May 8, 2023
Acquisition Enumera Molecular Acquires Progenity Liquid Biopsy Tech, Raises $12.5M in Series A Round · enumeramolecular.com
May 4, 2022
Raised a round Venture round $18.7M · SEC Form D
2022
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2026 | $12.3M | — | SEC Form D |
| Venture round | May 2022 | $18.7M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Enumera Molecular, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Matthew CooperExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Valius Sciences is a diagnostics and bioinformatics company building comprehensive DNA, RNA and protein assessments of tumors for cancer…
Feel Therapeutics is a Digital Precision Medicine company bringing objective data and passive measurement into the field of Mental…
By testing the response of a patient’s own cancer cells against many treatment options, we help physicians and patients make truly informed…
Precious MD is developing a companion diagnostic to identify the lung cancer patients who benefit from receiving EGFR inhibiting ...
DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug…
Transforming Treatment in Immunology. Living at the crossroads of precision medicine and AI, Scipher Medicine is a precision immunology…
People
Matthew Cooper
Executive Officer, Director
Dan Kidle
Director
Elaine Heron
Director
Sundaresh Brahmasandra
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Arboretum VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Ann Arbor
United States
HQ
Enumera Molecular
50-200 est. staff